News
A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...
Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...
15h
Stocktwits on MSNNovo Nordisk Wins Another Legal Battle Against Compounding Of Wegovy, Ozempic: Retail’s BullishNovo Nordisk (NVO) announced on Friday that it has secured a legal victory against compounders selling unauthorized versions ...
Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...
Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...
Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...
The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...
Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.
Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.
The Columbia County Spring Fair is back in town, but this time with some policy changes amid disruptions last week.
The Lessie B. Price Center advertised their fitness programs for seniors and educational programs for youth at their open ...
18hon MSN
On Thursday, Reuters reported weak U.S. prescription data is contributing to investor concerns that Novo Nordisk is no longer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results